America Great Health (AAGH) financial statements (2020 and earlier)
Company profile
| Business Address |
1609 W VALLEY BLVD UNIT 338A ALHAMBRA, CA 91803 |
| State of Incorp. | CA |
| Fiscal Year End | June 30 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | 6/30/2013 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 0 | 4 | 9 | 24 | 39 | |||
| Cash and cash equivalents | 0 | 4 | 9 | 24 | 39 | |||
| Receivables | 0 | 0 | ||||||
| Other undisclosed current assets | 240 | (20) | ||||||
| Total current assets: | 0 | 4 | 249 | 24 | 20 | |||
| Noncurrent Assets | ||||||||
| Long-term investments and receivables | 13 | |||||||
| Long-term investments | 13 | |||||||
| Other undisclosed noncurrent assets | 0 | |||||||
| Total noncurrent assets: | 13 | 0 | ||||||
| TOTAL ASSETS: | 13 | 4 | 249 | 24 | 20 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 20 | 8 | 4 | 81 | 9 | 10 | ||
| Accounts payable | 4 | 81 | 9 | 10 | ||||
| Accrued liabilities | 8 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 20 | |||||||
| Due to related parties | 101 | 44 | 120 | 400 | 30 | |||
| Other undisclosed current liabilities | 51 | 50 | ||||||
| Total current liabilities: | 121 | 52 | 175 | 481 | 39 | 60 | ||
| Noncurrent Liabilities | ||||||||
| Other undisclosed noncurrent liabilities | 535 | |||||||
| Total noncurrent liabilities: | 535 | |||||||
| Total liabilities: | 121 | 52 | 175 | 1,017 | 39 | 60 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | (107) | (48) | (1,093) | (998) | (353) | (227) | ||
| Preferred stock | 500 | |||||||
| Common stock | 49 | |||||||
| Common stock, share subscribed but unissued, subscriptions receivable | 87 | |||||||
| Additional paid in capital | 3,062 | 3,062 | 550 | |||||
| Retained earnings (accumulated deficit) | (3,170) | (3,110) | (2,143) | (998) | (353) | 189 | ||
| Other undisclosed stockholders' equity attributable to parent | (553) | |||||||
| Other undisclosed stockholders' equity | 5 | |||||||
| Total stockholders' equity: | (107) | (48) | (1,093) | (992) | (353) | (227) | ||
| Other undisclosed liabilities and equity | 1,168 | 188 | ||||||
| TOTAL LIABILITIES AND EQUITY: | 13 | 4 | 249 | 24 | (315) | 20 | ||
Income statement (P&L) ($ in thousands)
| 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | 6/30/2013 | ||
|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 3,174 | 43 | 7 | ||||
| Cost of revenue (Cost of Goods and Services Sold) | (2,959) | (59) | |||||
| Gross profit: | 216 | (16) | 7 | ||||
| Operating expenses | (58) | (48) | (123) | ||||
| Operating income (loss): | (58) | (48) | 93 | (16) | 7 | ||
| Nonoperating expense | (0) | ||||||
| Foreign currency transaction loss, before tax | (1) | ||||||
| Interest and debt expense | 55 | 1 | |||||
| Income (loss) from continuing operations before income taxes: | (59) | (48) | 148 | (16) | 8 | ||
| Income tax expense | (1) | ||||||
| Income (loss) from continuing operations: | (59) | (48) | 148 | (16) | 8 | ||
| Loss from discontinued operations | (919) | ||||||
| Net income (loss): | (59) | (967) | 148 | (16) | 8 | ||
| Net income attributable to noncontrolling interest | 10 | ||||||
| Other undisclosed net loss attributable to parent | (1,309) | (629) | (117) | ||||
| Net loss attributable to parent: | (59) | (967) | (1,151) | (645) | (109) | ||
| Other undisclosed net income available to common stockholders, basic | 10 | ||||||
| Net loss available to common stockholders, diluted: | (59) | (967) | (1,141) | (645) | (109) | ||
Comprehensive Income ($ in thousands)
| 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | 6/30/2013 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (59) | (967) | 148 | (16) | 8 | ||
| Comprehensive income (loss): | (59) | (967) | 148 | (16) | 8 | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 10 | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (59) | (967) | 158 | (16) | 8 | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.